The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae

Journal of Clinical Pathology

Volumn 52, Issue 2, 1999, Pages 99-102

  Wong, Y K ^a   Sueur, J M ^b   Fall, C H D ^c   Orfila, J ^b   Ward, M E ^d  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b Biobanque de Picardie   (France)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chlamydia; Microimmunofluorescence test; Time resolved fluoroscopic immunoassay

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHLAMYDOPHILA PNEUMONIAE; CROSS REACTION; ENZYME IMMUNOASSAY; ENZYME SPECIFICITY; FEMALE; FLUOROSCOPY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0032949591     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.2.99     Document Type: Article

References (13)

1. 1 Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8.
2. 2 Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart-disease and acute myocardial-infarction. Lancet 1988;ii;983-6.
3. 3 Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970;70:367-74.
4. 4 Domeika K, Brade L, Mardh PA, et al. Characterization of serum antibody response to chlamydiae in patients with sexually acquired reactive arthritis. FEMS Immunol Med Microbiol 1997;19:191-202.
5. 5 Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode-Island evidence of serologic cross-reactivity. Chest 1993;104:208-13.
6. 6 Ozanne G, Lefebvre J. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can J Microbiol 1992;38:1185-9.
7. 7 Suonpää M, Markela E, Ståhlberg T, et al. Europium-labelled streptavidin as a highly sensitive universal label. J Immunol Methods 1992;149:247-53.
8. 8 Fall CHD, Goggin PM, Hawtin P, et al. Growth in infancy, infant feeding, childhood living conditions, and Helicoacter pylori infection at age 70. Arch Dis Child 1997;77:310-14.
9. 9 Eb F, Orfila J. Serotyping of Chlamydia psittaci by the micro-immunofluorescence test isolates of ovine origin. Infect Immun 1982;37:1289-91.
10. 10 Schachter J. Human Chlamydia psittacci infection. In: Oriel D, Ridgway G, Schachter J, et al, eds. Chlamydial infections. New York: Cambridge University Press, 1986:311-20.
11. 11 Peeling RW, Wang SP, Grayston JT, et al. Chlamydia serology: inter-laboratory variation in microimmunofluorescence results. In: Stephens RS, Byrne GI, Christiansen G, et al, eds. Chlamydial infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. San Francisco: International Chlamydia Symposium, 1998:159-62.
12. 12 Ekman MR, Leinonen M, Syrjala H, et al. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993;12:756-60.
13. 13 Ladany S, Black CM, Farshy CE, et al. Enzyme-immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol 1989;27:2778-83.